A detailed history of Pfg Investments, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 20,850 shares of AUPH stock, worth $118,428. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,850
Previous 45,400 54.07%
Holding current value
$118,428
Previous $408 Million 74.41%
% of portfolio
0.01%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$4.93 - $9.31 $121,031 - $228,560
-24,550 Reduced 54.07%
20,850 $104 Million
Q4 2023

Jan 17, 2024

BUY
$7.13 - $9.49 $713 - $949
100 Added 0.22%
45,400 $408 Million
Q3 2023

Nov 06, 2023

SELL
$7.77 - $12.27 $7,770 - $12,270
-1,000 Reduced 2.16%
45,300 $352 Million
Q1 2023

May 11, 2023

BUY
$5.94 - $11.27 $275,022 - $521,801
46,300 New
46,300 $507 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $806M
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.